Motor neurons are a well-defined, although heterogeneous group of cells res
ponsible for transmitting information from the central nervous system to th
e locomotor system. Spinal motor neurons are specified by soluble factors p
roduced by structures adjacent to the primordial spinal cord, signaling thr
ough homeodomain proteins. Axonal pathfinding is regulated by cell-surface
receptors that interact with extracellular ligands and once synaptic connec
tions have formed, the survival of the somatic motor neuron is dependent on
the provision of target-derived growth factors, although nontarget-derived
factors, produced by either astrocytes or Schwann cells, are also potentia
lly implicated. Somatic motor neuron degeneration leads to profound disabil
ity, and multiple pathogenetic mechanisms including aberrant growth factor
signaling, abnormal neurofilament accumulation, excitotoxicity, and autoimm
unity have been postulated to be responsible. Even when specific deficits h
ave been identified, for example, mutations of the superoxide dismutase-l g
ene in familial amyotrophic sclerosis and polyglutamine expansion of the an
drogen receptor in spinal and bulbar muscular atrophy, the mechanisms by wh
ich somatic motor neuronal degeneration occurs remain unclear. In order to
treat motor system degeneration effectively, we will need to understand the
se mechanisms more thoroughly.